Staphylococcus Aureus Network Adaptive Platform Trial (NCT05137119)
🩺 Plain-English Summary (8th-Grade Level)
The Staphylococcus aureus Network Adaptive Platform (SNAP) trial is an International Multi-Centered Randomised Adaptive Platform Clinical Trial to evaluate a range of interventions to reduce mortality for patients with Staphylococcus Aureus bacteraemia (SAB).
Who can join: Review the eligibility criteria below.
Location: Houston Methodist Research Institute — Houston, Texas
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (161 Sites)
Showing the first 25 of 161 sites.
- Houston Methodist Research Institute — Houston, Texas
- Canberra Hospital — Garran, Australia Capital Territory
- Blacktown Hospital — Blacktown, New South Wales
- Royal Prince Alfred Hospital — Camperdown, New South Wales
- Concord Repatriation and General Hospital — Concord, New South Wales
- St Vincent's Hospital Sydney — Darlinghurst, New South Wales
- Nepean Hospital — Kingswood, New South Wales
- St George Hospital — Kogarah, New South Wales
- Liverpool Hospital — Liverpool, New South Wales
- John Hunter Hospital — New Lambton Heights, New South Wales
- John Hunter Children's Hospital — Newcastle, New South Wales
- Orange Health Service — Orange, New South Wales
- Prince of Wales Hospital — Randwick, New South Wales
- Sydney Children's Hospital — Randwick, New South Wales
- The Children's Hospital at Westmead — Westmead, New South Wales
- Westmead Hospital — Westmead, New South Wales
- Wollongong Hospital — Wollongong, New South Wales
- Royal Darwin Hospital — Tiwi, Northern Territory
- Sunshine Coast University Hospital — Birtinya, Queensland
- Cairns Hospital — Cairns, Queensland
- Royal Brisbane and Women's Hospital — Herston, Queensland
- Ipswich Hospital — Ipswich, Queensland
- Logan Hospital — Meadowbrook, Queensland
- Redcliffe Hospital — Redcliffe, Queensland
- Robina Hospital — Robina, Queensland
📞 Contact the Study Coordinator
Phone: +61 (03) 8344 1623
Email: lauren.barina@unimelb.edu.au
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Staphylococcus Aureus Bacteremia
- Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia — Melbourne, Victoria
- Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia — Calgary, Alberta
- Evaluating Simplified Layered Consent for Clinical Trials — Calgary, Alberta
- Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia — Brighton, Colorado
Explore by condition: All Staphylococcus Aureus Bacteremia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.